HALLE/SAALE, Germany, 8 May 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), has the honour to invite its shareholders to its annual shareholders meeting to be held on Wednesday, 10 June 2015 at 11.00 am (CEST), in the Leonardo Royal Hotel Berlin Alexanderplatz, Otto-Braun-Straße 90, 10249 Berlin, Germany.

The relevant documents can be found at http://www.probiodrug.de/investors/annual-shareholders-meeting-2015/.

For more information, please contact:
Dr Konrad Glund, CEO
Email: contact@probiodrug.de

Hume Brophy
Mary Clark, Supriya Mathur, Hollie Vile
Tel: +44 (0) 203 440 5653
Email: probiodrug@humebrophy.com